Med. Klinik I: Gastroenterologie und Hepatologie, Pneumologie und Allergologie, Endokrinologie und Diabetologie sowie Ernährungsmedizin -
PD Dr. Dr. Oliver Schröder

Expertise

Diagnostik und Therapie chronisch entzündlicher Darmkrankheiten sowie deren Komplikationen
Epidemiologie und Versorgungsforschung
Klinische Therapiestudien
Targetsuche an Patientenmaterialien

Methoden und Geräte

Rekrutierung von Patienten für Therapiestudien
Rekrutierung von Patienten zur Gewinnung forschungsrelevanter Proben

Mitarbeiter

PD Dr. Dr. Oliver Schröder (Arbeitsgruppenleiter)
Dr. Irina Blumenstein
Dr. Johannes Hausmann

Publikationen

Blumenstein I, Bock H, Weber C, Rambow A, Tacke W, Kihn R, Pfaff R, Orlemann S, Schaeffer R, Schröder O, Dignass A, Hartmann F, Stein J. Health care and cost of medication for inflammatory bowel disease in the Rhein-Main region, Germany: A multicenter, prospective, internet-based study. Inflamm Bowel Dis (2008) 14: 53-60.
Schröder O, Naumann M, Shastri Y, Povse N, Stein J. Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin. Aliment Pharmacol Ther (2007) 26: 1035-42.
Gasché C, Berstad A, Befrits R, Beglinger C, Dignass A, Erichsen K, Gomollon F, Hjortswang H, Koutroubakis I, Kulnigg S, Oldenburg B, Rampton D, Schröder O, Stein J, Travis S, Van Assche G. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis (2007) 13: 1545-53.
Schröder O, Blumenstein I, Stein J. Combining infliximab with methotrexate for the induction and maintenance of remission in refractory Crohn's disease: a controlled pilot study. Eur J Gastroenterol Hepatol (2006) 18: 11-16.
Schröder O, Mickisch O, Seidler U, de Weerth A, Dignass AU, Herfarth H, Reinshagen M, Schreiber S, Junge U, Schrott M, Stein J. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease - a randomized, controlled, open-label multicenter study. Am J Gastroenterol (2005) 100: 2503-2509.
Schröder O, Schrott M, Blumenstein I, Jahnel J, Dignass AU, Stein J. A pilot study for the evaluation of safety and tolerability of intravenous high-dose iron sucrose in patients with iron deficiency anemia due to gastrointestinal blood loss. Z Gastroenterol (2004) 42: 663-667.
Schröder O, Blumenstein I, Schulte-Bockholt A, Stein J. Combining infliximab and methotrexate in fistulising Crohn's disease resistant or intolerant to azathioprine. Aliment Pharmacol Ther (2004) 19: 295-301.
Schröder O, Naumann M, Stein J. Lack of association between serum anti-Saccharomyces cerevisisae antibodies and therapeutic response to infliximab in patients with refractory Crohn’s disease. Aliment Pharmacol Ther (2004) 20: 823-824.
Schröder O, Stein J. Low dose methotrexate in inflammatory bowel disease – current status and future directions. Am J Gastroenterol (2003) 98: 530-537.
Hirche TO, Russler J, Schröder O, Schuessler G, Kappeser P, Caspary WF, Dietrich CF. The value of routinely performed ultrasonography in patients with Crohn disease. Scand J Gastroenterol (2002)37: 1178-1183.